Danicamtiv: Myosin Activator Shows Genotype-Specific LVEF Gains in DCM Tags Dilated Cardiomyopathy TPHT_others Read more about Danicamtiv: Myosin Activator Shows Genotype-Specific LVEF Gains in DCM
STORM-PE: Mechanical Thrombectomy Beats Anticoagulation Alone in First RCT for Intermediate-High Risk PE Tags TPHT_others TINC_others Pulmonary Embolism Read more about STORM-PE: Mechanical Thrombectomy Beats Anticoagulation Alone in First RCT for Intermediate-High Risk PE
Mavacamten Reduces NT-proBNP and hs-cTnI in Symptomatic Nonobstructive HCM Tags TPHT_others Read more about Mavacamten Reduces NT-proBNP and hs-cTnI in Symptomatic Nonobstructive HCM
Beta-Blocker Withdrawal After MI With Preserved LVEF Shows No Increase in Ischemic Events Tags TPHT_others Read more about Beta-Blocker Withdrawal After MI With Preserved LVEF Shows No Increase in Ischemic Events
Beta-Blocker Use After MI Shows LVEF-Dependent Outcome Differences Tags TPHT_others Read more about Beta-Blocker Use After MI Shows LVEF-Dependent Outcome Differences
Early High-Dose Beta-Blocker Initiation Appears Safe in HFrEF With Hypertension Tags TPHT_others Read more about Early High-Dose Beta-Blocker Initiation Appears Safe in HFrEF With Hypertension
AHA 2025 Sessions: How Do Cilostazol and Pentoxifylline Compare for Cognitive Outcomes in ASCVD? Tags TPHT_others Read more about AHA 2025 Sessions: How Do Cilostazol and Pentoxifylline Compare for Cognitive Outcomes in ASCVD?
AHA 2025 Sessions: Aspirin and P2Y12 Inhibitor Monotherapy Show Similar Outcomes in CAD Tags TPHT_others Read more about AHA 2025 Sessions: Aspirin and P2Y12 Inhibitor Monotherapy Show Similar Outcomes in CAD
AHA 2025 Sessions: DOACs and Warfarin Show Similar Efficacy for LVT After Acute MI Tags TPHT_others Read more about AHA 2025 Sessions: DOACs and Warfarin Show Similar Efficacy for LVT After Acute MI
SGLT2 Inhibitors Reduce Mortality in Transthyretin Amyloid Cardiomyopathy Tags TPHT_others Read more about SGLT2 Inhibitors Reduce Mortality in Transthyretin Amyloid Cardiomyopathy